DE60008270D1 - Verfahren zur herstellung von oxazolinen aus tetrahydrofuranen - Google Patents

Verfahren zur herstellung von oxazolinen aus tetrahydrofuranen

Info

Publication number
DE60008270D1
DE60008270D1 DE60008270T DE60008270T DE60008270D1 DE 60008270 D1 DE60008270 D1 DE 60008270D1 DE 60008270 T DE60008270 T DE 60008270T DE 60008270 T DE60008270 T DE 60008270T DE 60008270 D1 DE60008270 D1 DE 60008270D1
Authority
DE
Germany
Prior art keywords
oxazolines
preparation
tetrahydrofuranes
producing
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60008270T
Other languages
English (en)
Other versions
DE60008270T2 (de
Inventor
Kharsa Busse
Edward Zook
Chaplin Borer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agouron Pharmaceuticals LLC
Original Assignee
Agouron Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharmaceuticals LLC filed Critical Agouron Pharmaceuticals LLC
Publication of DE60008270D1 publication Critical patent/DE60008270D1/de
Application granted granted Critical
Publication of DE60008270T2 publication Critical patent/DE60008270T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE60008270T 1999-10-21 2000-10-19 Verfahren zur herstellung von oxazolinen aus tetrahydrofuranen Expired - Fee Related DE60008270T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16069599P 1999-10-21 1999-10-21
US160695P 1999-10-21
PCT/US2000/028815 WO2001029013A1 (en) 1999-10-21 2000-10-19 Process for preparing oxazolines from tetrahydrofurans

Publications (2)

Publication Number Publication Date
DE60008270D1 true DE60008270D1 (de) 2004-03-18
DE60008270T2 DE60008270T2 (de) 2004-07-15

Family

ID=22578030

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60008270T Expired - Fee Related DE60008270T2 (de) 1999-10-21 2000-10-19 Verfahren zur herstellung von oxazolinen aus tetrahydrofuranen

Country Status (21)

Country Link
US (3) US6403799B1 (de)
EP (1) EP1224177B1 (de)
JP (2) JP2003512361A (de)
KR (1) KR100706938B1 (de)
CN (3) CN1539834A (de)
AT (1) ATE259360T1 (de)
AU (1) AU775783B2 (de)
BR (1) BR0015229A (de)
CA (1) CA2387997C (de)
CZ (1) CZ20021361A3 (de)
DE (1) DE60008270T2 (de)
DK (1) DK1224177T3 (de)
ES (1) ES2215737T3 (de)
HK (2) HK1051365A1 (de)
HU (1) HUP0203214A3 (de)
IL (1) IL149197A0 (de)
PL (1) PL364878A1 (de)
PT (1) PT1224177E (de)
RU (1) RU2242468C2 (de)
SI (1) SI1224177T1 (de)
WO (1) WO2001029013A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2872491T3 (da) 2012-07-11 2021-08-09 Blueprint Medicines Corp Inhibitorer af fibroblastvækstfaktorreceptoren
CN110028491B (zh) 2013-10-25 2022-02-11 缆图药品公司 纤维母细胞生长因子受体抑制剂
WO2015108992A1 (en) 2014-01-15 2015-07-23 Blueprint Medicines Corporation Heterobicyclic compounds and their use as fgfr4 receptor inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US5863950A (en) 1993-01-15 1999-01-26 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
SG43809A1 (en) 1993-02-26 1997-11-14 Schering Corp 2-benzyl-polycyclic guanine derivatives and process for preparing them
US5527829A (en) 1994-05-23 1996-06-18 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
AU717637B2 (en) * 1995-09-26 2000-03-30 Agouron Pharmaceuticals, Inc. Production of amide derivatives and intermediates therefor
DE69637770D1 (de) 1995-09-26 2009-01-15 Agouron Pharma Verfahren zur herstellung von amidderivaten und ihren zwischenverbindungen
US5962725A (en) * 1996-09-05 1999-10-05 Agouron Pharmaceuticals, Inc. Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
US5925759A (en) * 1996-09-05 1999-07-20 Agouron Pharmaceuticals, Inc. Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
US6001851A (en) * 1997-03-13 1999-12-14 Agouron Pharmaceuticals, Inc. HIV protease inhibitors

Also Published As

Publication number Publication date
US20020038033A1 (en) 2002-03-28
PT1224177E (pt) 2004-06-30
US6472534B2 (en) 2002-10-29
US20030023092A1 (en) 2003-01-30
AU775783B2 (en) 2004-08-12
CN1266140C (zh) 2006-07-26
JP2008007522A (ja) 2008-01-17
RU2242468C2 (ru) 2004-12-20
DE60008270T2 (de) 2004-07-15
EP1224177B1 (de) 2004-02-11
HUP0203214A2 (hu) 2003-01-28
IL149197A0 (en) 2002-11-10
CN1390210A (zh) 2003-01-08
KR20020047255A (ko) 2002-06-21
CA2387997C (en) 2006-06-13
KR100706938B1 (ko) 2007-04-11
US6403799B1 (en) 2002-06-11
BR0015229A (pt) 2002-07-23
PL364878A1 (en) 2004-12-27
HUP0203214A3 (en) 2005-01-28
CN1162408C (zh) 2004-08-18
CN1539832A (zh) 2004-10-27
HK1068880A1 (en) 2005-05-06
HK1051365A1 (en) 2003-08-01
CA2387997A1 (en) 2001-04-26
JP2003512361A (ja) 2003-04-02
WO2001029013A1 (en) 2001-04-26
SI1224177T1 (en) 2004-06-30
DK1224177T3 (da) 2004-05-03
ES2215737T3 (es) 2004-10-16
ATE259360T1 (de) 2004-02-15
CZ20021361A3 (cs) 2003-03-12
AU8029000A (en) 2001-04-30
CN1539834A (zh) 2004-10-27
EP1224177A1 (de) 2002-07-24

Similar Documents

Publication Publication Date Title
DE60135646D1 (de) Verfahren zur herstellung von radiomarkierten platin-chemotherapeutischen mitteln
DE60001657D1 (de) Verfahren zur herstellung von n-(4-cyan-3-trifluormethylphenyl)-3-(4-flurophenylsulfonyl)-2-hydroxy-2-methylpropionamid
DE60010510D1 (de) Verfahren zur herstellung von mischungen von alkoholen/ketonen
ATE259360T1 (de) Verfahren zur herstellung von oxazolinen aus tetrahydrofuranen
ATE270275T1 (de) Verfahren zur herstellung von 2-aryl-3-aryl-5- halogen-pyridinen, verwendbar als cox-2 inhibitoren
ATE250057T1 (de) Verfahren zur herstellung von 1-(1h)- benzoquinolizin-3-on derivaten
ATE278702T1 (de) Verfahren zur synthese von phosphorothioat- oligonukelotiden
ATE252543T1 (de) Verfahren zur herstellung chiraler (s)-2,3- disubstituierter 1-propylamin-derivate
DE60015563D1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
DE69908761D1 (de) Verfahren zur herstellung von hiv-protease inhibitoren
ATE275541T1 (de) Chemisches verfahren zur stereoselektiven synthese von r-(-)-carnitin
ATE271551T1 (de) Verfahren zur herstellung von n-(1-(s)- ethoxycarbonyl-3-phenylpropyl)-l-alanin-n- carboxyanhydrid
DE50112449D1 (de) Verfahren zur herstellung von 3,3-diarylpropylaminen
DE60106778D1 (de) Verfahren zur herstellung von vitronectin-rezeptorantagonisten
ATE402182T1 (de) Verfahren zur herstellung von grignardverbindungen
ATE330612T1 (de) Verfahren zur herstellung von benazeprilhydrochloride
DE69810653T2 (de) Verfahren zur wiederverwertung eines nebenproduktes aus der diltiazem-synthese
ATE399756T1 (de) Verfahren zur herstellung von alpha, beta- ungesattigten ami dverbindungen
DE60131660D1 (de) Verfahren zur asymetrischen synthese von substituierten 1,4-dihydropyridin-derivaten
DE69906283D1 (de) Verfahren zur herstellung von geschützten 3-amino-1,2-dihydroxypropanacetal und derivate davon
DE60119575D1 (de) Verfahren zur synthese von beta-lactamen
ATE469119T1 (de) Verfahren zur herstellung von polymorphen von sertralin hydrochlorid
ATE257823T1 (de) Piperidinverbindungen und verfahren zu deren herstellung
ATE404540T1 (de) Verfahren zur herstellung von 1-substituierten 5- chlor-4methylpyrazolen
DE60128336D1 (de) Eine zwischenverbindung und verfahren zu deren herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee